Vident Investment Advisory’s Bausch Health BHC Stock Holding History

Vident Investment Advisory’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-11,996	Closed	-$279K	–	933
2018 Q2	$279K	Buy	11,996 +191	+2%	+$3.95K	0.01%	810
2018 Q1	$203K	Buy	+11,805	New	+$220K	0.01%	863
2016 Q2	–	Sell	-98,636	Closed	-$2.59K	–	377
2016 Q1	$2.59K	Buy	98,636 +23,843	+32%	+$1.76M	0.16%	258
2015 Q4	$10.4M	Buy	74,793 +24,136	+48%	+$2.71M	1.31%	2
2015 Q3	$9.04M	Buy	50,657 +3,106	+7%	+$724K	1.25%	2
2015 Q2	$10.6M	Buy	47,551 +26,727	+128%	+$5.93M	1.41%	3
2015 Q1	$4.14M	Buy	+20,824	New	+$3.69M	0.83%	4

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vident Investment Advisory's BHC Position: Q3 2018 in Review

Vident Investment Advisory sold out of Bausch Health (BHC) in Q3 2018, closing a stake of 11,996 shares — an estimated $279K sold.

Vident Investment Advisory first reported a position in BHC in Q1 2015 and held it in 7 quarters. The position peaked at $10.6M in Q2 2015. 332 funds tracked by Wall St. Rank hold BHC as of Q3 2018.

Vident Investment Advisory reported no remaining Bausch Health position as of Q3 2018 after selling out during the quarter.
Vident Investment Advisory sold 11,996 Bausch Health shares in Q3 2018, an estimated $279K.
Vident Investment Advisory first reported a position in Bausch Health in Q1 2015 and held it in 7 quarters.
Vident Investment Advisory's Bausch Health position peaked at $10.6M in Q2 2015.
332 funds tracked by Wall St. Rank held Bausch Health as of Q3 2018.

Based on Vident Investment Advisory's 13F filing for Q3 2018, filed 14 Nov 2018.